vs
CHOICE HOTELS INTERNATIONAL INC（CHH）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
CHOICE HOTELS INTERNATIONAL INC的季度营收约是REPLIGEN CORP的1.7倍（$340.6M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs 5.9%，领先0.8%），REPLIGEN CORP同比增速更快（13.6% vs 2.3%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -11.5%）
凯悦酒店国际集团（Choice Hotels International）是总部位于美国马里兰州北贝塞斯达的跨国酒店集团，为全球规模最大的酒店连锁企业之一，旗下拥有从高端到经济型的多元酒店品牌。截至2024年末，集团在全球46个国家和地区特许经营近7600家酒店，客房总数超65万间。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
CHH vs RGEN — 直观对比
营收规模更大
CHH
是对方的1.7倍
$197.9M
营收增速更快
RGEN
高出11.3%
2.3%
净利率更高
RGEN
高出0.8%
5.9%
两年增速更快
RGEN
近两年复合增速
-11.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $340.6M | $197.9M |
| 净利润 | $20.0M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 17.6% | 9.0% |
| 净利率 | 5.9% | 6.7% |
| 营收同比 | 2.3% | 13.6% |
| 净利润同比 | -54.4% | 143.9% |
| 每股收益（稀释后） | $0.44 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHHRGEN
| Q1 26 | $340.6M | — | ||
| Q4 25 | $390.1M | $197.9M | ||
| Q3 25 | $447.3M | $188.8M | ||
| Q2 25 | $426.4M | $182.4M | ||
| Q1 25 | $332.9M | $169.2M | ||
| Q4 24 | $389.8M | $174.1M | ||
| Q3 24 | $428.0M | $154.9M | ||
| Q2 24 | $435.2M | $154.1M |
净利润CHHRGEN
| Q1 26 | $20.0M | — | ||
| Q4 25 | $63.7M | $13.3M | ||
| Q3 25 | $180.0M | $14.9M | ||
| Q2 25 | $81.7M | $14.9M | ||
| Q1 25 | $44.5M | $5.8M | ||
| Q4 24 | $75.8M | $-30.3M | ||
| Q3 24 | $105.7M | $-654.0K | ||
| Q2 24 | $87.1M | $3.3M |
毛利率CHHRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率CHHRGEN
| Q1 26 | 17.6% | — | ||
| Q4 25 | 26.0% | 9.0% | ||
| Q3 25 | 31.8% | 8.9% | ||
| Q2 25 | 29.2% | 7.6% | ||
| Q1 25 | 24.0% | 3.9% | ||
| Q4 24 | 30.6% | -17.7% | ||
| Q3 24 | 35.5% | -5.1% | ||
| Q2 24 | 30.5% | 1.0% |
净利率CHHRGEN
| Q1 26 | 5.9% | — | ||
| Q4 25 | 16.3% | 6.7% | ||
| Q3 25 | 40.2% | 7.9% | ||
| Q2 25 | 19.2% | 8.2% | ||
| Q1 25 | 13.4% | 3.4% | ||
| Q4 24 | 19.4% | -17.4% | ||
| Q3 24 | 24.7% | -0.4% | ||
| Q2 24 | 20.0% | 2.2% |
每股收益（稀释后）CHHRGEN
| Q1 26 | $0.44 | — | ||
| Q4 25 | $1.35 | $0.24 | ||
| Q3 25 | $3.86 | $0.26 | ||
| Q2 25 | $1.75 | $0.26 | ||
| Q1 25 | $0.94 | $0.10 | ||
| Q4 24 | $1.56 | $-0.55 | ||
| Q3 24 | $2.22 | $-0.01 | ||
| Q2 24 | $1.80 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $43.9M | $767.6M |
| 总债务越低越好 | $2.0B | $542.2M |
| 股东权益账面价值 | $137.4M | $2.1B |
| 总资产 | $2.9B | $2.9B |
| 负债/权益比越低杠杆越低 | 14.58× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资CHHRGEN
| Q1 26 | $43.9M | — | ||
| Q4 25 | $45.0M | $767.6M | ||
| Q3 25 | $52.6M | $748.7M | ||
| Q2 25 | $58.6M | $708.9M | ||
| Q1 25 | $40.1M | $697.2M | ||
| Q4 24 | $40.2M | $757.4M | ||
| Q3 24 | $58.6M | $784.0M | ||
| Q2 24 | $60.4M | $809.1M |
总债务CHHRGEN
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $542.2M | ||
| Q3 25 | $1.9B | $537.9M | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $1.8B | $525.6M | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.9B | — |
股东权益CHHRGEN
| Q1 26 | $137.4M | — | ||
| Q4 25 | $181.2M | $2.1B | ||
| Q3 25 | $149.8M | $2.1B | ||
| Q2 25 | $-26.2M | $2.1B | ||
| Q1 25 | $-63.9M | $2.0B | ||
| Q4 24 | $-45.3M | $2.0B | ||
| Q3 24 | $-96.2M | $2.0B | ||
| Q2 24 | $-146.8M | $2.0B |
总资产CHHRGEN
| Q1 26 | $2.9B | — | ||
| Q4 25 | $2.9B | $2.9B | ||
| Q3 25 | $2.9B | $2.9B | ||
| Q2 25 | $2.7B | $2.9B | ||
| Q1 25 | $2.6B | $2.9B | ||
| Q4 24 | $2.5B | $2.8B | ||
| Q3 24 | $2.5B | $2.8B | ||
| Q2 24 | $2.5B | $2.9B |
负债/权益比CHHRGEN
| Q1 26 | 14.58× | — | ||
| Q4 25 | 10.52× | 0.26× | ||
| Q3 25 | 12.81× | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流CHHRGEN
| Q1 26 | — | — | ||
| Q4 25 | $85.7M | $25.7M | ||
| Q3 25 | $68.7M | $48.1M | ||
| Q2 25 | $95.6M | $28.6M | ||
| Q1 25 | $20.5M | $15.0M | ||
| Q4 24 | $82.9M | $39.2M | ||
| Q3 24 | $122.9M | $49.3M | ||
| Q2 24 | $111.9M | $42.2M |
自由现金流CHHRGEN
| Q1 26 | — | — | ||
| Q4 25 | $64.1M | $17.6M | ||
| Q3 25 | $49.1M | $43.4M | ||
| Q2 25 | $65.4M | $21.5M | ||
| Q1 25 | $-15.0M | $11.4M | ||
| Q4 24 | $57.4M | $33.6M | ||
| Q3 24 | $92.6M | $42.3M | ||
| Q2 24 | $86.6M | $37.4M |
自由现金流率CHHRGEN
| Q1 26 | — | — | ||
| Q4 25 | 16.4% | 8.9% | ||
| Q3 25 | 11.0% | 23.0% | ||
| Q2 25 | 15.3% | 11.8% | ||
| Q1 25 | -4.5% | 6.8% | ||
| Q4 24 | 14.7% | 19.3% | ||
| Q3 24 | 21.6% | 27.3% | ||
| Q2 24 | 19.9% | 24.3% |
资本支出强度CHHRGEN
| Q1 26 | — | — | ||
| Q4 25 | 5.5% | 4.1% | ||
| Q3 25 | 4.4% | 2.5% | ||
| Q2 25 | 7.1% | 3.9% | ||
| Q1 25 | 10.7% | 2.1% | ||
| Q4 24 | 6.5% | 3.2% | ||
| Q3 24 | 7.1% | 4.5% | ||
| Q2 24 | 5.8% | 3.1% |
现金转化率CHHRGEN
| Q1 26 | — | — | ||
| Q4 25 | 1.35× | 1.93× | ||
| Q3 25 | 0.38× | 3.23× | ||
| Q2 25 | 1.17× | 1.92× | ||
| Q1 25 | 0.46× | 2.57× | ||
| Q4 24 | 1.09× | — | ||
| Q3 24 | 1.16× | — | ||
| Q2 24 | 1.28× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CHH
| Franchise and management fees | $149.6M | 44% |
| Other | $135.8M | 40% |
| Owned hotels | $30.4M | 9% |
| Partnership services and fees | $24.7M | 7% |
RGEN
暂无分部数据
